We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.56B
AUM Growth
+$82.6M
Cap. Flow
+$9.05M
Cap. Flow %
0.58%
Top 10 Hldgs %
50.01%
Holding
338
New
18
Increased
55
Reduced
91
Closed
21

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
COWZ icon
Pacer US Cash Cows 100 ETF
COWZ
+$11.8M
3
JPM icon
JPMorgan Chase
JPM
+$5.37M
4
AAPL icon
Apple
AAPL
+$5.1M
5
BAC icon
Bank of America
BAC
+$3.88M

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.75M
2
SCHW
Charles Schwab
SCHW
+$4.62M
3
MSFT icon
Microsoft
MSFT
+$4.07M
4
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$4.06M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.66M

Sector Composition

Rank Sector Weight
1 Healthcare 11.26%
2 Technology 8.53%
3 Financials 8.13%
4 Communication Services 4.48%
5 Energy 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
301
Precigen
PGEN
$2.45B
$174K 0.01%
164,209
– –
PETS icon
302
PetMed Express
PETS
$43M
$162K 0.01%
10,000
– –
HTZWW
303
Hertz Global Holdings Warrants
HTZWW
$112M
$118K 0.01%
13,300
+1,800
+16% +$16.8K
MYN icon
304
BlackRock MuniYield New York Quality Fund
MYN
$376M
$102K 0.01%
10,000
– –
AKLI
305
DELISTED
Akili Inc
AKLI
$90.5K 0.01%
56,554
– –
CLSD
306
DELISTED
Clearside Biomedical
CLSD
$86.3K 0.01%
5,533
– –
VEEE icon
307
Twin Vee PowerCats
VEEE
$7.14M
$82.2K 0.01%
131
– –
RLYB icon
308
Rallybio
RLYB
$88.1M
$74.6K ﹤0.01%
1,633
– –
MGNX icon
309
MacroGenics
MGNX
$256M
$71.7K ﹤0.01%
10,000
– –
GLS
310
DELISTED
Gelesis Holdings, Inc.
GLS
$64.3K ﹤0.01%
395,035
– –
KG
311
Kestrel Group
KG
$66.3M
$51.8K ﹤0.01%
1,238
– –
CGTX icon
312
Cognition Therapeutics
CGTX
$98.9M
$48.5K ﹤0.01%
24,500
– –
KRRO icon
313
Korro Bio
KRRO
$197M
$23.1K ﹤0.01%
917
– –
ETWO.WS
314
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$22.9K ﹤0.01%
29,400
+1,500
+5% +$1.33K
VERU icon
315
Veru
VERU
$46.7M
$18.8K ﹤0.01%
1,621
– –
NMAD
316
Nomad Power Solutions
NMAD
$71.9M
$16.5K ﹤0.01%
+2,000
New +$16.1K
SPPI
317
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$7.5K ﹤0.01%
10,000
– –
AWK icon
318
American Water Works
AWK
$26.8B
– –
-1,500
Closed -$229K
BAM icon
319
Brookfield Asset Management
BAM
$87.1B
– –
-47,186
Closed -$1.35M
BDX icon
320
Becton Dickinson
BDX
$50B
– –
-800
Closed -$203K
DHR icon
321
Danaher
DHR
$145B
– –
-867
Closed -$204K
GSK icon
322
GSK
GSK
$101B
– –
-10,324
Closed -$363K
HRMY icon
323
Harmony Biosciences
HRMY
$2.32B
– –
-4,629
Closed -$255K
IAT icon
324
iShares US Regional Banks ETF
IAT
$687M
– –
-7,200
Closed -$343K
INTC icon
325
Intel
INTC
$509B
– –
-18,684
Closed -$494K
10 11 12
13
14

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q1 2023 Portfolio in Review

As of Q1 2023, Northeast Financial Consultants held 338 positions worth $1.56B, up 5.6% from $1.48B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Northeast Financial Consultants's Q1 2023 filing shows 18 new, 55 increased, 91 reduced and 21 closed positions. Its largest new stake was Texas Instruments: 11,750 shares worth $2.19M. The largest sale was Vanguard S&P 500 ETF, an estimated $4.75M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

  • Northeast Financial Consultants's largest Q1 2023 buy was Texas Instruments: 11,750 shares worth $2.19M.
  • Northeast Financial Consultants added most to Pfizer in Q1 2023, an estimated $30M increase.
  • Northeast Financial Consultants's biggest Q1 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.75M.
  • Northeast Financial Consultants fully exited Brookfield Asset Management in Q1 2023, selling an estimated $1.35M.
  • Northeast Financial Consultants's ten largest holdings make up 50% of its $1.56B portfolio in Q1 2023.
  • Northeast Financial Consultants opened 18 new positions and closed 21 in Q1 2023.
  • Northeast Financial Consultants's portfolio value rose 5.6% quarter-over-quarter to $1.56B.

Based on Northeast Financial Consultants's 13F filing for Q1 2023, filed 15 May 2023.